| Salbutamol |
6618/11.01.2010 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
11.58 |
2.32 |
13.9 |
8% |
0.93 |
12.51 |
2.5 |
15.01 |
20% |
2.32 |
14.83 |
2.97 |
17.8 |
КЦ-1660/25.06.2010 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3785 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva B.V., Нидерландия |
Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г.; НСР-17173/09.11.2018 |
КЦ-700/09.03.2009 |
24.03.2009 |
02.12.2018 |
Активен |
663 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г. |
КЦ-700/09.03.2009 |
24.03.2009 |
02.06.2017 |
Неактивен |
663 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015 |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
663 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.8 |
1.16 |
6.96 |
7% |
0.41 |
6.21 |
1.24 |
7.45 |
20% |
1.16 |
7.37 |
1.47 |
8.84 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012; НСР-17061/26.10.2018 |
10.11.2018 |
02.12.2018 |
Активен |
1355 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.67 |
1.13 |
6.8 |
7% |
0.4 |
6.07 |
1.21 |
7.28 |
20% |
1.13 |
7.2 |
1.44 |
8.64 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012 |
11.09.2012 |
11.09.2012 |
Неактивен |
1355 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.67 |
1.13 |
6.8 |
7% |
0.4 |
6.07 |
1.21 |
7.28 |
20% |
1.13 |
7.2 |
1.44 |
8.64 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012 |
11.09.2012 |
11.09.2012 |
Неактивен |
1355 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
19.11 |
3.82 |
22.93 |
6% |
1.15 |
20.26 |
4.05 |
24.31 |
18% |
3.44 |
23.7 |
4.74 |
28.44 |
|
НСР-1944/06.12.2013; НСР-10087/18.08.2016 |
24.12.2013 |
02.10.2016 |
Заличен |
2342 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
19.11 |
3.82 |
22.93 |
6% |
1.15 |
20.26 |
4.05 |
24.31 |
18% |
3.44 |
23.7 |
4.74 |
28.44 |
|
НСР-1944/06.12.2013 |
24.12.2013 |
24.12.2013 |
Неактивен |
2342 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
22.86 |
4.57 |
27.43 |
6% |
1.37 |
24.23 |
4.85 |
29.08 |
18% |
4.11 |
28.34 |
5.67 |
34.01 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
2342 |
| Reboxetine |
990065 |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Италия |
31.33 |
6.27 |
37.6 |
4% |
1.25 |
32.58 |
6.52 |
39.1 |
16% |
5.01 |
37.59 |
7.52 |
45.11 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009; НСР-20812/13.02.2020 |
28.02.2020 |
02.03.2020 |
Активен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009 |
25.03.2009 |
02.01.2019 |
Неактивен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015 |
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
658 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
13.12 |
2.62 |
15.74 |
6% |
0.79 |
13.91 |
2.78 |
16.69 |
18% |
2.36 |
16.27 |
3.25 |
19.52 |
Цената се заличава с решение НСР-2231/20.12.2013 |
КЦРР-1071/26.07.2012 |
12.09.2012 |
12.09.2012 |
Заличен |
1357 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
14.08 |
2.82 |
16.9 |
6% |
0.84 |
14.92 |
2.98 |
17.9 |
18% |
2.53 |
17.45 |
3.49 |
20.94 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
1357 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
395.57 |
79.11 |
474.68 |
4% |
10 |
405.57 |
81.11 |
486.68 |
16% |
25 |
430.57 |
86.11 |
516.68 |
|
НСР-7784/28.12.2015; HCP-10174/31.08.2016; НСР-12821/26.05.2017 г. |
10.06.2017 |
02.07.2017 |
Активен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
414.26 |
82.85 |
497.11 |
4% |
10 |
424.26 |
84.85 |
509.11 |
16% |
25 |
449.26 |
89.85 |
539.11 |
|
НСР-7784/28.12.2015; HCP-10174/31.08.2016 |
02.10.2016 |
02.10.2016 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
424.83 |
84.97 |
509.8 |
4% |
10 |
434.83 |
86.97 |
521.8 |
16% |
25 |
459.83 |
91.97 |
551.8 |
|
НСР-7784/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
428.13 |
85.63 |
513.76 |
4% |
10 |
438.13 |
87.63 |
525.76 |
16% |
25 |
463.13 |
92.63 |
555.76 |
|
НСР-4999/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3344 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
440.69 |
88.14 |
528.83 |
4% |
10 |
450.69 |
90.14 |
540.83 |
16% |
25 |
475.69 |
95.14 |
570.83 |
|
НСР-1076/02.09.2013 |
24.09.2013 |
24.09.2013 |
Неактивен |
3344 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
15.9 |
3.18 |
19.08 |
6% |
0.95 |
16.85 |
3.37 |
20.22 |
18% |
2.86 |
19.71 |
3.94 |
23.65 |
промяна на обстоятелства НСР-9775/14.07.2016; НСР-17431/06.12.2018 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017; НСР-16586/24.08.2018 |
08.09.2018 |
02.01.2019 |
Активен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
15.9 |
3.18 |
19.08 |
6% |
0.95 |
16.85 |
3.37 |
20.22 |
18% |
2.86 |
19.71 |
3.94 |
23.65 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017; НСР-16586/24.08.2018 |
08.09.2018 |
02.10.2018 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
16.04 |
3.21 |
19.25 |
6% |
0.96 |
17 |
3.4 |
20.4 |
18% |
2.89 |
19.89 |
3.98 |
23.87 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013; НСР-12833/26.05.2017 |
10.06.2017 |
02.07.2017 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, Prolonged release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия; Pfizer Manufacturing Deutschland GmbH, Германия |
18.07 |
3.61 |
21.68 |
6% |
1.08 |
19.15 |
3.83 |
22.98 |
18% |
3.25 |
22.4 |
4.48 |
26.88 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
02.08.2016 |
Неактивен |
1651 |
| Venlafaxine |
9800389 |
EFECTIN ER 150, prolonged‐release capsule, hard, 150, mg, Pack: 28 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Ireland Pharmaceuticals, Ирландия ; Pfizer Manufacturing Deutschland GmbH, Германия |
18.07 |
3.61 |
21.68 |
6% |
1.08 |
19.15 |
3.83 |
22.98 |
18% |
3.25 |
22.4 |
4.48 |
26.88 |
промяна на обстоятелства НСР-9775/14.07.2016 |
КЦРР-2181/06.02.2013 |
03.03.2013 |
03.03.2013 |
Неактивен |
1651 |